Cargando…
Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
Envelope protein-targeted vaccines for flaviviruses are limited by concerns of antibody-dependent enhancement (ADE) of infections. Nonstructural protein 1 (NS1) provides an alternative vaccine target that avoids this risk since this protein is absent from the virion. Beyond its intracellular role in...
Autores principales: | Wessel, Alex W., Doyle, Michael P., Engdahl, Taylor B., Rodriguez, Jessica, Crowe, James E., Diamond, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510529/ https://www.ncbi.nlm.nih.gov/pubmed/34634945 http://dx.doi.org/10.1128/mBio.02440-21 |
Ejemplares similares
-
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
por: Oliphant, Theodore, et al.
Publicado: (2005) -
A potently neutralizing human monoclonal antibody targeting an epitope in the West Nile virus E protein preferentially recognizes mature virions
por: Goo, Leslie, et al.
Publicado: (2018) -
Genetically delivered antibody protects against West Nile virus
por: Pereboev, Alexander, et al.
Publicado: (2008) -
Infection with Non-Lethal West Nile Virus Eg101 Strain Induces Immunity that Protects Mice against the Lethal West Nile Virus NY99 Strain
por: Kumar, Mukesh, et al.
Publicado: (2014) -
Protective immune responses against West Nile virus are primed by distinct complement activation pathways
por: Mehlhop, Erin, et al.
Publicado: (2006)